Key Takeaways

  • Multiple legal firms told Amanda Blank that building an institutional med spa roll-up across strict regulatory markets was too complex to execute.
  • In states like Washington and California, Corporate Practice of Medicine rules require target clinical practices to remain 100% owned by licensed doctors.
  • Founders Beauty Group isolates non-clinical operations inside a Management Services Organization, funding deals through special purpose vehicles that hold dedicated operating entities.
  • A Master Services Agreement extracts financial value from the target clinics, legally sweeping operational cash flow out of the doctor-owned practice into the management platform.
  • Secret-shopping prospective clinical acquisitions provides ground-truth operating data that clinical seller representations frequently obscure.

The Legal Wall Most Roll-Ups Hit

Amanda Blank wanted to buy medical spas. When she took the plan to legal counsel, several firms flatly refused to take the work. “I was turned down from a few legal firms and who said this is too comp,” Blank recalls.

Most private equity sponsors looking at fragmented healthcare retail run into the same barrier: the Corporate Practice of Medicine. In states like Washington and California, non-physicians cannot legally own a medical practice. They cannot hire doctors to deliver care, and they cannot take direct equity in medical operations.

To non-specialist counsel, this looks like an impossible hurdle for a traditional buyout model. If an investor cannot own the equity, they cannot run a standard consolidation playbook. But high-volume consumer aesthetics trade at attractive cash-flow multiples precisely because casual buyers run away from this compliance wall. Overcoming it requires separating legal clinical control from day-to-day business management.

How the MSO-MSA Engine Moves Cash

Blank bypassed the legal deadlock by bifurcating every asset into two parallel organizations: a clinical practice and a corporate management company.

First, the clinical entity stays completely in physician hands. As Blank explains, “the PLLC's are 100% doctorowned in the state of Washington.” Because non-physicians cannot touch that equity, an independent physician partner holds legal ownership of the professional limited liability company. That structure satisfies state medical boards and ensures all clinical oversight stays strictly with licensed professionals.

Second, the investor builds a corporate vehicle designed to handle all non-medical functions: human resources, facility leases, vendor procurement, marketing, and scheduling software. Blank set up an investment structure to finance the platform: “We created an SPV acquired the or SPV that held an new cos.”

Finally, the two sides connect through a formal contract. The management company bills the clinical practice for administrative services. As Blank puts it, “the master services agreement and it sweeps the cash from the PLLC's to the MSO.” The clinical entity pays management fees, shifting the financial yield into the investor-owned management platform without violating professional ownership statutes.

Mystery Shopping as Primary Due Diligence

Financial engineering solves the regulatory ownership challenge, but it does not tell a buyer whether a med spa is actually viable. Blank emphasizes that before drafting contracts, “First step is finding a company to buy.”

In medical aesthetics, seller disclosures often hide severe operational problems: inconsistent injector training, sloppy patient intake, or poor hygiene standards that create catastrophic medical malpractice exposure. To verify operations before putting capital at risk, Blank relies on secret-shopping targets firsthand. Experiencing the patient journey unannounced reveals whether a clinic has repeatable institutional protocols or just a charismatic practitioner hiding broken compliance.

Why It Matters

CPOM enforcement separates amateur aggregators from institutional consolidators in physician-adjacent retail. Sponsors who build legally sound MSO structures unlock cash flows in heavily regulated states like California and Washington while keeping clinical liability walled off inside independent doctor entities. When platform sponsors pair verified field diligence with clean cash-sweeping agreements, they turn regulatory barriers into high-margin acquisition moats.